Cargando…

Programmed cell death-ligand 1 expression predicts poor treatment response and prognostic value in esophageal squamous cell carcinoma patients without esophagectomy

Research on association between programmed cell death ligand 1 (PD-L1) expression in cancer cells and prognosis of esophageal squamous cell carcinoma (ESCC) has been controversial and has focused on patients with surgical resection. We aimed to investigate impact of PD-L1 on treatment response and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fang, Zhu, Xiuyuan, Zhang, Qi, Zhou, Ping, Hao, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351667/ https://www.ncbi.nlm.nih.gov/pubmed/34297698 http://dx.doi.org/10.18632/aging.203326

Ejemplares similares

Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2016)

Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma
por: Hirahara, Noriyuki, et al.
Publicado: (2016)

Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
por: Meng, Jin, et al.
Publicado: (2018)

Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
por: Kim, Ryul, et al.
Publicado: (2016)

Prognostic significance of epidermal growth factor receptor and programmed cell death-ligand 1 co-expression in esophageal squamous cell carcinoma
por: Jiang, Guoxiang, et al.
Publicado: (2023)

Programmed death‐ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor
por: Zhang, Wencheng, et al.
Publicado: (2017)

Prognostic Value of SDF-1α Expression in Patients with Esophageal Squamous Cell Carcinoma Receiving Esophagectomy
por: Chen, Yen-Hao, et al.
Publicado: (2020)

Prognostic value of esophageal cancer immune prognostic index in advanced esophageal squamous cell carcinoma patients with anti‐programmed cell death‐1 therapy
por: Lu, Jiangyue, et al.
Publicado: (2023)

Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy
por: Su, Dan, et al.
Publicado: (2015)

Prognostic value of preoperative weight loss-adjusted body mass index on survival after esophagectomy for esophageal squamous cell carcinoma
por: Zhang, Han-Lu, et al.
Publicado: (2020)

Prognostic Significance of Glasgow Prognostic Score in Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Prognostic Function of Programmed Cell Death-Ligand 1 in Esophageal Squamous Cell Carcinoma Patients Without Preoperative Therapy: A Systematic Review and Meta-Analysis
por: Cui, Hongxia, et al.
Publicado: (2021)

Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy
por: Chen, Pengxiang, et al.
Publicado: (2017)

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients
por: Wang, Shuo, et al.
Publicado: (2021)

High programmed death-ligand 1 expression is a poor prognostic indicator for esophageal squamous cell carcinoma and is correlated with two-field lymph node metastasis
por: Liang, Mingqiang, et al.
Publicado: (2020)

The Prognostic Value of Oligo-Recurrence Following Esophagectomy for Esophageal Cancer
por: Kang, Minsang, et al.
Publicado: (2023)

Metastatic to negative lymph node ratio demonstrates significant prognostic value in patients with esophageal squamous cell carcinoma after esophagectomy
por: Duan, Xiao-Feng, et al.
Publicado: (2017)

Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy
por: Huang, Wan-Ting, et al.
Publicado: (2019)

Commentary: The Prognostic Value of Oligo-Recurrence Following Esophagectomy for Esophageal Cancer
por: Mine, Shinji
Publicado: (2023)

The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy
por: Gao, Qiu-Fang, et al.
Publicado: (2018)

Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma
por: Tsutsumi, Satoshi, et al.
Publicado: (2017)

Comparison of Up-Front Minimally Invasive Esophagectomy versus Open Esophagectomy on Quality of Life for Esophageal Squamous Cell Cancer
por: Li, Zhenhua, et al.
Publicado: (2021)

Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma
por: Chew, Mianxin, et al.
Publicado: (2020)

Prognostic significance of serum carcinoembryonic antigen and squamous cell carcinoma antigen in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
por: Hu, Jia, et al.
Publicado: (2020)

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma
por: Xiao, Wen-jun, et al.
Publicado: (2019)

Safety and Feasibility of Esophagectomy Following Neoadjuvant Immunotherapy Combined with Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Gu, Yi-Min, et al.
Publicado: (2022)

Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: A retrospective study
por: Yu, Fan, et al.
Publicado: (2022)

Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
por: Zhao, Zhiyong, et al.
Publicado: (2021)

Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy
por: Jia, Yang, et al.
Publicado: (2017)

Mediastinoscopy-assisted esophagectomy for T2 middle and lower thoracic esophageal squamous cell carcinoma patients
por: Wang, Jun, et al.
Publicado: (2018)

Prognostic significance of neutrophil-to-lymphocyte ratio in middle thoracic esophageal squamous cell carcinoma patients undergoing radical esophagectomy
por: Hu, Jia, et al.
Publicado: (2020)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
por: Zheng, Yan, et al.
Publicado: (2020)

Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
por: Zhu, Zhenhua, et al.
Publicado: (2017)

Programmed cell death ligand 1 expression in esophageal squamous cell carcinoma: a comparative analysis of three different assays
por: Guo, Lei, et al.
Publicado: (2021)

The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis
por: Zhao, Shu, et al.
Publicado: (2018)

Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment
por: Da, Liangshan, et al.
Publicado: (2023)

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
por: Uemura, Motohide, et al.
Publicado: (2021)

Long-term outcomes of mediastinoscopic esophagectomy in early esophageal squamous cell carcinoma: 269 cases study
por: Zheng, Liang, et al.
Publicado: (2019)

Super-late pulmonary recurrence after radical esophagectomy for esophageal squamous cell carcinoma
por: Umemura, Akira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0h37msunchm2hkdft0i8jh45c9